Jill M. Johnsen
Articles
-
Mar 26, 2024 |
onlinelibrary.wiley.com | Cedric Hermans |Jill M. Johnsen |Nicola Curry
DISCLOSURES Cedric Hermans: research funding: Bayer, BioMarin, CSL Behring, Novo Nordisk, Pfizer, Shire/Takeda, and Sobi; honoraria and speaker's bureau: Bayer, CAF-DCF, CSL Behring, Hoffmann-La Roche, LFB, Novo Nordisk, Octapharma, Pfizer, Shire/Takeda, Sobi, and UniQure. Jill Johnsen: research funding: Octapharma and consultancy: Octapharma, Takeda, CSL Behring, Biomarin.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →